Biohit Oyj (HLSE: BIOBV)
Health Care · Health Care Equipment & Supplies · FI
€2.60
-0.38% today · -7.8% 1Y
Biohit Oyj (HLSE: BIOBV) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $46.33M and employs 46 people.
Over the last twelve months the share price has lost 7.8%, trading between 2.20 and 3.78.
Tweenvest scores Biohit Oyj across four factors: quality 74/100, value 62/100, growth 49/100. Its strongest factor is quality.
BIOBV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $46.33M
- Revenue (TTM)
- $18.43M
- P/E
- 13.11
- EPS
- 0.20
- Dividend yield
- —
- Beta (5Y)
- 0.58
- 52-week high
- €3.78
- 52-week low
- €2.20
- Avg volume (3M)
- —
- Shares outstanding
- 15.21M
- Employees
- 46
- Next earnings
- —
About Biohit Oyj
Helsinki-based Biohit Oyj is a biotechnology company that specializes in developing and distributing diagnostic tests and analytical systems worldwide for healthcare providers and research institutions. Their comprehensive portfolio of diagnostic solutions includes the GastroPanel test, designed for evaluating stomach conditions and associated risks, alongside tests for active vitamin B12 levels (Biohit Active B12) and vitamin D status (Biohit Total). They also offer the Biohit Calprotectin test, various methods for detecting Helicobacter pylori infection from biopsy samples, the ColonView Quick Test for identifying fecal occult blood, rapid tests for Lactose Intolerance and Celiac Disease, and the GA-map Dysbiosis test for detailed gut microbiota DNA analysis. Beyond diagnostics, Biohit manufactures products that bind carcinogenic acetaldehyde into harmless compounds, such as Acetium capsules for individuals with low stomach acidity, and Acetium lozenges, which neutralize acetaldehyde in smokers' saliva. The company also supplies monoclonal antibodies crucial for research in cellular pathology, neurobiology, oncology, and human gastric biomarkers. Additionally, their offerings extend to laboratory instrumentation, including microplate readers, strip washers, quick test readers, and the ThunderBolt automated immunoassay analyzer, complemented by comprehensive service laboratory provisions. Biohit Oyj was founded in 1988.
- ISIN
- FI0009005482
- Founded
- 1988
- Listed since
- Jan 3, 2000
- Exchange
- OMX Nordic Exchange Helsinki
- Currency
- EUR
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $380.25 | +0.38% |
| Stryker CorporationNYSE: SYK | $126.37B | $332.00 | +0.77% |
| Medtronic plcNYSE: MDT | $119.49B | $93.76 | +0.44% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €162.35 | -0.52% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.